A Phase I Study of Oral UE2343 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Healthy
Interventions
DRUG

UE2343

Oral capsule

DRUG

Placebo

Oral capsule

Trial Locations (1)

CF48 4DR

Simbec Research, Merthyr Tydfil

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

Simbec Research

INDUSTRY

lead

University of Edinburgh

OTHER

NCT01770886 - A Phase I Study of Oral UE2343 in Healthy Subjects | Biotech Hunter | Biotech Hunter